1-42929018-G-A

Variant summary

Our verdict is Pathogenic.
+12 Pathogenic
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 12 classification points (ACGS-UK Somatic Oncogenicity v2025). O1_ModerateO2_Very_StrongO3_Moderate

The NM_006516.4(SLC2A1):c.988C>T (p.Arg330*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant is predicted to lead to nonsense-mediated mRNA decay (NMD). The gene SLC2A1 is a tumor suppressor gene (CancerMine: 3 TSG, 14 oncogene, 1 driver citations). The gene SLC2A1 is a known oncogene (CancerMine: 3 TSG, 14 oncogene, 1 driver citations). The gene SLC2A1 is a cancer driver gene (CancerMine: 3 TSG, 14 oncogene, 1 driver citations). The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (BayesDel (noAF)) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). The variant has been observed in cBioPortal in 1 sample across 1 study and 1 cancer type; somatic enrichment level: NONE (Observed in at most one deduplicated cBioPortal case.). This exact variant is curated in the UniProt human variants database as Uncertain Significance.

Frequency

Genomes: not found (cov: 33)

Consequence

SLC2A1
NM_006516.4 stop_gained

Scores

3
4

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:10O:1

Conservation

PhyloP100: 4.55

Publications

3 publications found
Variant links:
Genes affected
SLC2A1 (HGNC:11005): (solute carrier family 2 member 1) This gene encodes a major glucose transporter in the mammalian blood-brain barrier. The encoded protein is found primarily in the cell membrane and on the cell surface, where it can also function as a receptor for human T-cell leukemia virus (HTLV) I and II. Mutations in this gene have been found in a family with paroxysmal exertion-induced dyskinesia. [provided by RefSeq, Apr 2013]
SLC2A1 Gene-Disease associations (from GenCC):
  • encephalopathy due to GLUT1 deficiency
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P
  • GLUT1 deficiency syndrome
    Inheritance: SD, AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, ClinGen
  • childhood onset GLUT1 deficiency syndrome 2
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
  • dystonia 9
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
  • epilepsy, idiopathic generalized, susceptibility to, 12
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary cryohydrocytosis with reduced stomatin
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • myoclonic-astatic epilepsy
    Inheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_006516.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Pathogenic. The variant received 12 points.

O1Established oncogenic variant
TSG gene: ClinVar germline P/LP ★★+ — Moderate (O1); O1 contributing sources (2.0 pts): ClinVar germline P/LP in TSG (★★)
O2Null variant in tumour suppressor gene
Frameshift/stop-gained, NMD predicted, LoF oncogenic mechanism — O2 very strong (+8); Use caution in the presence of multiple transcripts; Gene confirmed as TSG in CancerMine (TSG: 3 citations, oncogene: 14 citations, driver: 1 citations).; Frameshift/stop-gained. NMD predicted: true. LoF mechanism: true. Downstream pathogenic count: 0.
O3Absent or very rare in population
Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = absent, AC = 0 — absent/extremely rare (O3 moderate [+2])

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_006516.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

SLC2A1 NM_006516.4
MANE Select
HGVSc / HGVSpc.988C>Tp.Arg330*
Exon rankExon 8 of 10
stop_gained
Prot: NP_006507.2UniProt: P11166

Ensembl Transcripts

SLC2A1 ENST00000426263.10
TSL:1MANE Select
HGVSc / HGVSpc.988C>Tp.Arg330*
Exon rankExon 8 of 10
stop_gained
Prot: ENSP00000416293.2UniProt: P11166
SLC2A1 ENST00000889577.1
HGVSc / HGVSpc.985C>Tp.Arg329*
Exon rankExon 8 of 10
stop_gained
Prot: ENSP00000559636.1UniProt: A0ACI8RFT3
SLC2A1 ENST00000958848.1
HGVSc / HGVSpc.988C>Tp.Arg330*
Exon rankExon 8 of 10
stop_gained
Prot: ENSP00000628907.1UniProt: A0ACI8V0G7

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 4 sources
GnomAD3 genomes
Cov:33
GnomAD4 exome
Cov:32
GnomAD4 genome
Cov:33
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.0000432
AC:1
Hom:0
AN:23172
Showing 4 sources

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
3
-
-
not provided (3)
2
-
-
Encephalopathy due to GLUT1 deficiency (3)
1
-
-
Childhood onset GLUT1 deficiency syndrome 2 (1)
1
-
-
Dystonia 9;C1837206:Hereditary cryohydrocytosis with reduced stomatin;C1842534:Childhood onset GLUT1 deficiency syndrome 2;C4551966:Encephalopathy due to GLUT1 deficiency (1)
1
-
-
Epilepsy;C4551563:Microcephaly;CN228659:intellectual deficiency (1)
1
-
-
GLUT1 deficiency syndrome 1, autosomal recessive (1)
1
-
-
Inborn genetic diseases (1)

Computational Scores

AlphaGenome AVI
Pathogenic35
BayesDel_addAF
Pathogenic0.58D
BayesDel_noAF
Pathogenic0.51
CADD
Pathogenic47
DANN
Uncertain1.0
Eigen
Uncertain0.67
Eigen_PC
Uncertain0.52
FATHMM_MKL
Uncertain0.94D
GPN-Star LLR
N/A-10
GPN-Star score
N/A10
Mutation Taster
N/A2/198disease causing (ClinVar)
PhyloP100
Uncertain4.5
RBP_binding_hub_radar
N/A0.92
RBP_regulation_power_radar
N/A2.6
Showing 14 of 14 scores

Splicing Scores

Pangolin (max)
Benign0.040
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

dbSNP: rs80359826;
hg19: chr1-43394689;
COSMIC: COSV65287339;
COSMIC: COSV65287339;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.